AT-501

· Medigen Vaccine Biologics Corp.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AT-501, covering 2016-08-22 to 2016-08-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Immunogenicity of H7N9 Influenza Vaccine (AT-501) in Healthy Adult Subjects [Phase 1, Phase 2]

See pricing